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It is critical for the depressive symptoms of adolescents to be recognized, evaluated, and 
treated. Depression can increase the risk for illness and interpersonal difficulties in the future and 
affect almost every aspect of an individual’s life.  Self-report measures are often utilized to 
assess depression, and when these measures are able to effectively detect depression, diagnosis 
and treatment are expedited.  In order to validate the usefulness and psychometric properties of a 
new self-report measure, existing measures are often used as one criterion by which to judge 
them.  The present study explored concurrent and discriminant validity of a new self-report 
depression measure, the Clinical Assessment of Depression (CAD; Bracken & Howell, 2004), 
with an established self-report measure, the Reynolds Adolescent Depression Scale (RADS; 
Reynolds, 1987).  The population for this investigation consisted of 122 adolescents (ages 13 to 
18), a group of 99 non-referred and a group of 23 individuals with a primary diagnosis of 
unipolar depression.  Strong, significant correlations ranging from .70 to .97 were found between 
the CAD and the RADS.  This study also found that the CAD is a sound instrument that can be 
used to discriminate between clinical and non-referred adolescent populations.  The CAD 
appears to have acceptable validity that supports its use with adolescent populations. 
 vi
 Review of the Literature 
It is imperative for society to gain insight into the disorder of depression.  Accurate 
identification and treatment of adolescent depression is essential to ensure the well being of 
young people.  Depression measures that currently exist assess depressive symptoms for specific 
age ranges, not across the lifespan.  A new depression scale has been developed that assesses 
depressive symptoms across the lifespan using one scale.  As this new measure is under 
development, it is crucial to evaluate it using an established measure for comparison purposes.  
As stronger assessment tools are developed, the better the chance of early, accurate identification 
and treatment.   
 This section will provide a review of the literature relevant to this investigation of the 
validity of the Clinical Assessment of Depression (CAD; Bracken & Howell, 2004) with the 
Reynolds Adolescent Depression Scale (RADS; Reynolds, 1987).  First, an overview of child 
and adolescent depression will be provided including incidence, symptomology, and diagnostic 
criteria.  Next, the psychometric assessment of depression in children and adolescents will be 
discussed.  Lastly, the purpose of the present investigation will be presented. 
Depression in Adolescents 
Depression is a psychological disorder that is often overlooked among child and 
adolescent populations.  Health care providers and family members of children and adolescents 
often view possible indicators of depression expressed by young people as typical mood swings 
and, as a result, the disorder remains under-diagnosed and untreated (Evans, Velsor, & 
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Schumacher, 2002; National Institute of Mental Health [NIMH], 2000).  Children and 
adolescents commonly find it difficult to identify and express the internal emotional state they 
are in, but often display classic symptoms such as low self-esteem, guilt, loss of interest in 
school activities, decreased school performance, and boredom (NIMH, 2000).  It is critical for 
the depressive symptoms of adolescents to be recognized, evaluated and treated, as depression 
can increase the risk for illness and interpersonal difficulties in the future and affect almost every 
aspect of that individual’s life (Evans et al., 2002; Stanard, 2000).          
The body of research concerning childhood and adolescent depression has increased over 
the past two decades and a knowledge base regarding childhood depression has consequently 
emerged.  Prevalence rates for major depression are comparable to that of adults, making 
depression a major health problem among youths.  The incidence of depression among youth in 
the United States ages 9-17 is estimated to be around five percent with between 1.5% and 4.7% 
being diagnosed with Major Depressive Disorder (Fritz, 1997; Pullen, Modrcin-McCarthy, & 
Graf, 2000; Stanard, 2000).  The prevalence of depressive disorders differs in countries 
throughout the world.  Past research indicates percentages ranging from 11.7% of adolescents in 
East Germany to 40% of Bulgarian adolescents.  In the United States, Canada, and Britain, the 
prevalence was found to be around 10% and in Poland, the percentage was around 30 (Boyd, 
Gullone, Kostanski, Ollendick, & Shek, 2000).  While prevalence rates may vary across 
countries, depression appears to be a universal construct of significant concern in children and 
adolescents.  
Gender and depression.  When looking at the prevalence rates of depression by gender, 
an equal number of boys and girls suffer from depression prior to adolescence. The percentage of 
adolescent boys identified as experiencing a depressed mood is between 20 and 35 percent; for 
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adolescent girls, the percentage rate is between 25 and 40 percent (Peterson et al., 1993).  
According to Reynolds (1992), 8 to 18 percent of school-aged youth have experienced a clinical 
level of depression. 
During adolescence, however, rates of unipolar depression (major depressive disorder, 
dysthymic disorder, or depressive disorder not otherwise specified) have been found to be higher 
for girls than for boys (Herson & Ammerman, 2000; Marcotte, Fortin, Potvin, & Papillon, 2002; 
Rutter, Graham, Chadwick, & Yule, 1976).  In a study comparing female and male mean scores 
on the Reynolds Adolescent Depression Scale (RADS) and the Beck Depression Inventory 
(BDI), Baron and Campbell (1993) examined whether females continue to exhibit higher mean 
scores on discriminating items.  It was found that females do in fact have higher mean scores on 
these items.  This supports the view that females characteristically report more depressive 
symptoms than males (Baron & Campbell, 1993).   
Diagnostic criteria.  In determining a diagnosis of depression for adolescents, the criteria 
set forth by the Diagnostic and Statistical Manual of Mental Disorders-4th Edition Text Revision 
([DSM-IV-TR] American Psychiatric Association [APA], 2000) must be met.  The DSM-IV-TR 
consists of three diagnostic categories for unipolar depressive disorders: major depressive 
disorder, dysthymic disorder, and depressive disorder not otherwise specified. 
 As a severe form of depression, Major Depressive Disorder is characterized by one or 
more Major Depressive Episodes.  These episodes last at least two weeks and consist of 
depressed mood and loss of interest in most all activities. The individual must also suffer from at 
least four additional symptoms of the following list: “changes in appetite or weight, sleep, and 
psychomotor activity; decreased energy; feelings of worthlessness or guilt; difficulty thinking, 
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concentrating, or making decisions; or recurrent thoughts of death or suicidal ideation, plans or 
attempts” (APA, 2000, p. 356).  
 A second unipolar depressive diagnostic category is Dysthymic Disorder.  This form of 
depression consists of a less severe symptom pattern than major depression; however, the 
symptoms are chronic in that they are experienced for at least one year.  With children and 
adolescents, symptoms must last at least one year and must include two or more of the following: 
irritability, poor self-esteem, poor social skills, feelings of hopelessness, and impaired school 
performance (APA, 2000). 
The third diagnostic category involving unipolar depression in the DSM-IV-TR is 
Depressive Disorder Not Otherwise Specified.  This form of depression includes depressive 
features consistent with that required to diagnose major depression or dysthymia, yet the 
symptom pattern does not meet the criteria for any other Depressive Disorders in severity, 
quantity, or duration. When there is inadequate or contradictory information, this form of 
depression may be used for diagnosis (APA, 2000). 
Adolescent symptoms.  While the same criteria are required for a diagnosis of Major 
Depressive Disorder in adolescents as in adults, the symptoms are commonly presented 
differently (Mash & Wolfe, 2002; Mellin & Beamish, 2002; Oster & Montgomery, 1995; 
Stanard, 2000).  Adolescents experiencing depressive disorders tend to exhibit more 
helplessness, fatigue, despair, lack of pleasure, suicidal thoughts, hypersomnia, and variations in 
weight than depressed adults (Evans et al., 2002; NIMH, 2000; Stanard, 2000).  Depressive 
Disorders during adolescence also tend to be more episodic, with phases of depression, followed 
by phases of better functioning (Mellin & Beamish, 2002).  Impairments in academic 
performances and relationships with others are often noted in adolescents experiencing clinical 
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levels of depression (Evans et al., 2002; Mellin & Beamish, 2002).  Adolescent depression may 
also be expressed in ways that do not resemble depressive symptoms, such as behavior problems, 
family problems, substance abuse, or rebellion (Mellin & Beamish, 2002).  There are also gender 
differences in the expression of depressive symptoms.  Males tend to exhibit more irritability, 
work inhibition, sleep disturbance, and social withdrawal while females tend to exhibit more 
body image distortion, loss of appetite, sadness, dissatisfaction, and weight loss (Baron & 
Campbell, 1993).  
Assessment of Depression 
Use of self-report scales.  The diagnosis of depression is reached after a 
comprehensive assessment in which information about the individual’s symptoms and 
behavior/behavior patterns are obtained.  Recommended practices in diagnosis are to gain such 
information primarily through a multimodal assessment approach utilizing clinical/diagnostic 
interviews with the child/adolescent or their parent(s), documentation of the child’s/adolescent's 
behavior over time through use of behavior checklists, and self-report measures to assess 
symptom pattern and severity.  While all of these  methods are important to use in a thorough 
assessment, self-report measures are frequently utilized to assess depression and are the focus for 
this investigation (Wright-Strawderman, Lindsey, Navarrete, & Slippo, 1996). 
Self-report measures are frequently used in social-emotional assessment (Marcotte et al., 
2002; Merrell, 1999; Reynolds, 1990; Stanard, 2000; Wright-Strawderman et al., 1996).  The 
utilization of such measures enables individuals to report their own internal thoughts, feelings, 
and emotions.  This allows for better first-hand information of an individual's internal experience 
of depression than what could be obtained from a third party’s observation of symptom patterns. 
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Objective self-report measures are often standardized instruments.  They require the 
completion of questions or items concerning an individual's perception of his or her social or 
emotional behavior and answers are compared to a population sample.  It has been proposed by 
Martin (1988) that self-report measures must have four essential characteristics present before 
being considered as objective measures: (a) adequate test-retest reliability, (b) standardized 
procedures, (c) provide normative data for comparison, and (d) adequate validity.  It is important 
to address Martin’s characteristics in the test development process. 
Types of rating scales.  Self report rating scales vary on the scope of the behaviors or 
symptomology covered.  There are some self-report measures available that deal with a broad 
range of symptomology, however there are also measures available that focus specifically on 
depressive symptomology, a narrow range of symptomology.  Such standardized measures that 
specifically assess adolescent depression include the Beck Depression Inventory-II (BDI-II; 
Beck, Steer, & Brown, 1996) and the Reynolds Adolescent Depression Scale (RADS; Reynolds, 
1987).  There are other measures that assess a broad range of symptomology, including 
depression (e.g., Behavior Assessment System for Children, Child Behavior Checklist), that are 
helpful as a screening device to provide depressive symptom information, however the RADS 
and the BDI-II provide more systematic and specific coverage of the symptoms of depression.   
The Reynolds Adolescent Depression Scale (RADS) was developed by William M. 
Reynolds in 1986.  This was the first depression scale developed specifically for use with 
adolescents and it was developed by selecting items based on symptomology described by the 
DSM-III for Major Depression and Dysthymic Disorder.  It is an accepted measure among 
clinicians (Merrell, 1990) and assesses depressive symptoms in adolescents ages 13 through 18.  
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The RADS can also be used for individuals outside of this age range who are in junior or senior 
high school settings.   
Martin’s evaluation criteria for objective self-report measures can be used to evaluate the 
RADS (1988).  There are four essential characteristics that a self-report measure should possess 
in order to be considered a good self-report measure.  The RADS has an established test-retest 
reliability ranging from .63 to .80 from studies that have been conducted (Platt, 1999; Reynolds 
1987).  Standardized administration procedures are utilized in the RADS.  Presentation of test 
items is done in a consistent manner and the responses are compared to responses of other 
individuals.  The RADS also provides normative data that allows  scores to be compared to a 
larger group of individuals and it has established validity (Platt, 1999; Reynolds 1987).  Based 
on these criteria, the RADS is an established self-report measure that provides reliable, norm 
referenced, valid information to the professionals who utilize it.    
The Clinical Assessment of Depression (CAD), developed by Bracken and Howell, is an 
instrument that is under development by Psychological Assessment Resources (PAR).  It was 
developed to answer the question as to whether or not depressive symptoms are consistent across 
the age range from childhood through adulthood.  The existing published measures of depression 
are designed either for adult or child populations.  The CAD was developed to assess depression 
among children, adolescents, and adults using a single form.   
As the CAD is currently in development, only limited information is available.  However, 
this measure has a test-retest reliability ranging from .81 to .87 and the author reports there is 
evidence for adequate validity.  The CAD is a standardized measure yielding age-related scores 
for the total measure and four subscales.  The presentation of test items is done in a consistent 
manner and item responses can be compared to responses of other individuals (B. A. Bracken, 
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personal communication, March 25, 2004).  The CAD appears to be a promising measure for use 
in the assessment of depression.   
Purpose of Present Investigation   
Self-report measures play an important role in the assessment of depression.  Due to the 
internalizing nature of depression, an individual is more in-tune to his or her own thoughts and 
feelings than what a third party can ascertain through observation (Merrell, 1999; Reynolds, 
1990; Stanard, 2000). When depression measures are able to effectively detect depression, 
diagnosis and treatment can be expediated.  In order to validate the usefulness and psychometric 
properties of new measures, existing measures are one criterion by which to judge new 
instruments.  According to the Standards for Educational and Psychological Testing (AERA, 
APA, & NCME, 1999), such investigations should be conducted prior to use in the field.  As 
noted previously, the RADS is considered to be a psychometrically adequate instrument that is 
used to assess depression in adolescents.  And it is reasonable to use the RADS as a criterion 
measure for establishing validity of similar measures under development.  The purpose of this 
investigation is to explore the concurrent validity of a measure under development, the Clinical 
Assessment of Depression (CAD), with an existing proven measure, the Reynolds Adolescent 
Depression Scale (RADS).  Classification efficacy of the CAD for diagnosing depression will 
also be explored.  The hypotheses for this investigation are as follows. 
1. The CAD total score, and subscales will evidence strong concurrent validity with the 
RADS total score for the combined total sample.  
2. The clinical group will evidence significantly higher mean scores on the CAD       
than the non-referred group and higher mean scores on the RADS than the non-
referred group.   
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In addition to the hypotheses above, the classification efficacy of the CAD was examined using 
the RADS as the criterion measure.
  
 
 
Method 
 
Participants 
 
The sample consisted of adolescents residing in south central Kentucky (ages 13 
to 18) who have either been diagnosed with Major Depressive Disorder, Dysthymia, or 
Depressive Disorder NOS (clinical group) or who have no diagnosis (non-referred group).  One 
hundred twenty two adolescents (ages 13 to 18), 57 males and 65 females comprised the clinical 
(n=23) and non-referred groups (n=99).   
The clinical sample consisted of individuals diagnosed with unipolar depression 
diagnoses including: Major Depressive Disorder (n=5), Dysthymia (n=2), or Depressive 
Disorder, NOS (n=14) according to DSM-IV-TR criteria (APA, 2000).  One participant was 
diagnosed with Major Depressive Disorder as a secondary diagnosis, and one participant was 
diagnosed with Cyclothymic Disorder.  The mean age for the clinical sample was 15.0 and 
consisted of 91.3% Caucasian participants and 8.7% minority participants.   
The non-referred group was composed of individuals from a high school in south central 
Kentucky.  Mean age for the non-referred group was 15.4 years.  The non-referred sample 
consisted of 91.9% Caucasian participants and 8.1 percent minority participants.  The total 
sample combining both groups consisted of 91.8% Caucasian and 8.2% minority participants. 
Instruments  
 Reynolds Adolescent Depression Scale (RADS).  The Reynolds Adolescent Depression 
Scale is a brief, 30-item, self-report measure for adolescents ages 13-18 that can be administered 
individually or in a group or orally to the reading disabled and takes about 10 minutes to 
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complete.  It requires a response by the adolescents that indicates how they usually feel.  The 
RADS is used as a screening measure for identifying depressive symptoms in school and clinical 
populations.  It is used for research on depression and has subscales that evaluate Dysphoric 
Mood, Anhedonia/ Negative Affect, Negative Self-Evaluation, and Somatic Complaints.  The 
RADS is also used for evaluation of treatment outcomes (Reynolds, 1987). 
According to the RADS Professional Manual, the internal consistency of the 
standardization sample for the RADS ranged from .909 to .939, with a total sample alpha of .922 
and split-half reliability with the same sample was .91.  Other internal consistency data obtained 
found results similar to these (Merrell, 1999).  The results of three studies that were conducted to 
examine test-retest reliability obtained coefficients of .80, .79, and .63.  Data support that this 
test is a reliable measure. 
Content validity assesses whether or not a test measures adequately a particular domain, 
such as depression, in this case.  Content validity was found by looking at the similarity of item 
content with depressive symptomology and item total scale correlations indicating item 
consistency.  Using a standardization sample of 2,296 adolescents, item total correlation 
coefficients were mainly in the .50s and .60s with median correlation being .53 (Platt, 1999).  
Using a sample of 111 high school adolescents, concurrent validity with the Hamilton 
Depression Rating Scale (HDRS) was found to be .83, which indicates a strong relationship 
between the two measures in their ability to assess depression (Davis, 1990; Platt, 1999).  A 
sample of 1054 adolescents (age 12-14) produced a correlation of .70 between the RADS and the 
Children’s Depression Inventory (Reynolds, 1987).  Brown, Overholser, Spirito, and Fritz’s 
study (as cited in Reynolds, 1992) reported a correlation of .64 in a sample of adolescent suicide 
attemptors.  Several supporting studies of construct validity were provided in the RADS manual 
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and successive studies have been published supporting its validity (Merrell, 1999).   When 
compared to other self-report measures of depression, the following correlations were reported: 
between the RADS and the Beck Depression Inventory correlations ranged from .68 to .76; 
correlations between the RADS and the CES-D (the Center for Epidemiological Studies 
Depression Scale) ranged from.74 to .76; the correlation between the RADS and the Self Rating 
Depression Scale was .72 (Davis, 1990; Platt, 1999; Reynolds, 1987). 
Platt (1999) describes the RADS as possessing several strengths.  It’s attractive 
appearance and inviting front cover give the test examinee a sense of ease when describing their 
feelings.  The instructions were found to be direct and easily understandable, and scoring of this 
instrument was found to be quick and easy (Platt, 1999).  The RADS also makes validity checks 
to account for truthfulness of respondents.  Supporting previous research also indicates that the 
RADS manual is well written and strongly documented (Merrell, 1999).  Merrell (1999) supports 
that the RADS is gaining acceptance throughout the clinical and research communities and is a 
strong supplement to the adolescent self-report instrumentation that is being used. 
Weaknesses mentioned by Pratt (1999) include the limited sample used in 
standardization.  While a large sample was used, it did not take into account racial diversity or 
more than one geographic location.  The test-retest reliability dropped over one year’s time.  This 
drop could have been influenced by external factors, for example therapeutic interventions or 
internal factors.     
  Clinical Assessment of Depression (CAD).  The CAD (Bracken & Howell, 2004) is 
currently in development by Psychological Assessment Resources.  It is a 50-item scale that 
takes approximately 10 minutes to complete.  The age range for this scale is 9 to 79 years.  The 
CAD assesses depressive symptomology on four subscales: Depressed Mood, Anxiety/Worry, 
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Diminished Interest, and Cognitive and Physical Fatigue.  Items in these categories were 
developed using wording and content appropriate for all ages.   
 Although the CAD is currently under development, pre-publication psychometric data 
were obtained (B. A. Bracken, personal communication, March 23, 2004).  CAD Total Scale 
score reliability ranged from .96 to .98 and vary little by age, race, and gender.  Subscale 
reliabilities are as follows: Depressed Mood subscale ranged from .95 to .97; Anxiety/Worry 
subscale ranged from .82 to .90; Diminished Interest subscale ranged from .79 to .92; and 
Cognitive and Physical fatigue subscale ranged from .79 to .91.  Variation of these subscales is 
largely due to sample size.  Test-retest reliability for the Total Scale score ranged from .81 to .87.  
Concurrent validity was established through correlations between the CAD Total Scale score and 
the Beck Depression Inventory (BDI-II; r = .71) and between the CAD Total Scale score and the 
RADS (r = .64).  The author reported confirmatory factor analyses support the four subscales 
structure of the instrument.   
 
Procedure 
Clinical group participants were recruited through private clinicians and psychiatric 
hospitals.  Once permission was obtained to solicit participants from these treatment providers, 
these providers were given packets and directions for distributing forms to parents/guardians.  
Each parent/guardian was given a packet containing a letter including the description of the study 
and an invitation to participate, two parent consent forms (WKU and PAR), a release of 
information form, an instruction sheet, an adolescent assent form, and the three depression scales 
(CAD, BDI-II, and RADS; see Appendix A for forms).  Data collection for this study overlapped 
with another investigation that necessitated the BDI-II be included in the packet.  Parents were 
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asked to complete the two consent forms and the release of information form.  The adolescents 
were asked to complete the assent form and the three depression scales.  Upon completion of the 
three depression scales and the consent and assent forms, participants were asked to place and 
seal the scales in one envelope and the consent and assent forms in a separate envelope.  The 
parent/guardian or participant then returned both packets to their clinician from whom the 
conductor of this study retrieved them. Participants were given a local fast food restaurant 
coupon that did not exceed $2.00 in value for their participation.  The researcher provided these 
coupons to the therapist who distributed them.  The researcher of this study then asked the 
therapist to complete the Clinician’s Record Form after a signed release form was obtained from 
the parent/guardian (see Appendix A).   
    Subjects comprising the non-referred group were solicited from a local high school.  For 
data collection at the high school, an introductory letter and consent form were sent home with 
one randomly selected 9th, 10th, 11th, and 12th grade classroom in a public high school in south 
central Kentucky (100 students; see Appendix B for forms).  Students who returned forms to the 
school received a local fast food restaurant coupon that did not exceed a $2.00 value.  A coupon 
was given for returning the consent form whether or not consent was granted.  The students for 
whom parental consent was obtained were asked to sign an assent form and complete three 
measures during school hours.  An appropriate time for completion of questionnaires, which was 
approximately 25 minutes, was determined between the researcher and the students’ teacher.  A 
coding system was used so that a student could be identified in the event of significant responses 
indicating depression or suicidal ideation.  Parents/guardians were notified by the researcher 
when significant ratings were obtained in the non-referred group.  Names were kept separate 
from all forms, with no names appearing on the forms.  All procedures for this study were 
  
 15
approved by Western Kentucky University’s Human Subjects Review Board in April 2003 (see 
Appendix C).     
  
  
Results 
This researcher had three purposes: (a) to examine the relationship between the CAD and 
the RADS, (b) to determine whether group differences existed between the clinical group and the 
non-referred group on the CAD and the RADS, and (c) to explore the hit rate or classification 
consistency when using the RADS as the criterion measure. 
The sample consisted of 122 adolescents ages 13 to 18 from south central Kentucky (57 
males and 65 females).  Twenty-three comprised the clinical group (10 males and 13 females); 
ninety-nine comprised the non-referred group.  Table 1 provides the mean score (M), the 
standard deviation (SD), and the standard error of the mean (SEM) for the raw scores on each 
measure for the clinical and non-referred groups. 
To examine the relationship between the CAD and the RADS, Pearson product-moment 
correlation coefficients were computed for the total raw scores for each scale and for each 
subscale of the CAD (Depressed Mood, Anxiety/Worry, Diminished Interest, and Cognitive and 
Physical Fatigue) with the RADS total score.  Using the Bonferroni approach to control for Type 
I error across the 12 correlations, a p value of less than .003 was established for significance.  
The results of the correlational analyses are presented in Table 2.  All of the 15 correlations were 
statistically significant.  Using Cohen’s (1988) effect sizes, the correlations obtained were 
classified within the strong range.  The results suggest strong concurrent validity between the 
total score on the RADS and the total score on the CAD, as well as between the RADS and each 
subscale on the CAD. 
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Table 1 
Sample Descriptive Statistics for the Raw Scores on the RADSa and the CADb 
   
 
      RADS                CAD 
      _______________________      _______________________ 
 
Sample       N        M        SD       SEM      N       M       SD       SEM  
Non-referred 
     Male      46     56.20    17.37     2.56     47       97.34    29.81     4.35  
     Female      52       65.62    18.73     2.60     52  107.12    29.29     4.06 
     Total       98     61.19    18.62     1.88     99    102.47    29.80     2.99 
Clinical 
     Male      10       57.90    11.80     3.73     10  106.40    26.07     8.25  
     Female      13      80.85    16.97     4.71     13  138.77    27.33     7.58 
     Total       23     70.87    18.69     3.90     23  124.70    30.90     6.44 
Total Sample 
     Male      56     57.05    16.43     2.20     57  101.87    29.18     3.86 
     Female      65     73.24    19.27     2.40     65  122.95    31.40     3.90 
     Total               121     63.03    18.94     1.72    122  106.66    31.12     2.82                     
 
Note.  Clinical sample consisted of individuals diagnosed primarily with Major  
 
Depressive Disorder, Dysthymia, or Depressive Disorder, NOS. 
 
aReynolds Adolescent Depression Scale.  bClinical Assessment of Depression. 
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Table 2            
Correlations of RADSa Total Score with CADSb Total Score and Scales                                       
 
Subscale 
 
1 
 
2 
 
3         
 
4 
 
 
5 
 
6 
1. CAD Total Score - .97* .93* .90* .86* .88* 
2. CAD, Depressed Mood - - .86* .84* .74* .86* 
3. CAD, Anxiety/Worry  - - - .78* .78* .84* 
4. CAD, Diminished Interest - - - - .77* .78* 
5. CAD, Cognitive and Physical 
    Fatigue 
 
- - - - - .70* 
6. RADS Total Score - - - - - - 
                                                                  
aReynolds Adolescent Depression Scale.  bClinical Assessment of Depression.   
 
* p < .004 
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To determine whether group differences existed between the clinical and non-referred 
groups, independent samples t tests were conducted to see how each of the two scales (RADS 
and CAD) could distinguish between the two groups (clinical and non-referred) mean scores.  
Levene’s Test for the Equality of Variances was computed due to the number of group 
participants being unequal.  All significance levels for the equality of variances test were found 
to be above .05.  Therefore the t test results were interpretable.  The tests were significant, t(119) 
= -2.24,  p = .027 for the RADS, and t(120) = -3.2,  p = .002 for the CAD.  The results support 
the hypothesis that the clinical group will evidence higher scores on each of the two scales than 
the non-referred group.  Participants in the clinical group displayed higher scores on both scales 
than participants in the non-referred group.     
Classification efficacy of the CAD was explored using the RADS as the criterion 
measure.  Bracken recommends using a T-score of 60 as the cutoff score for distinguishing 
between depressed and non-depressed individuals (B. Bracken, personal communication, March 
23, 2004).  Using the RADS cutoff raw score of 77, and comparing CAD categories of depressed 
and non-depressed to actual RADS findings, a 2 x 2 contingency table was computed (Table 3) 
for the total sample.  An examination of the association between the RADS cutoff score and the 
CAD cutoff score resulted in a χ2 = 51.74, (p < .000).  An examination of cell proportions 
indicated that the CAD and the RADS, as to their diagnostic category for the total sample, 
consistently identified 84% of the adolescents.   
Further contingency tables were computed in order to understand the classification 
efficacy of the CAD and the RADS using group membership (clinical and non-referred) as the 
criterion.  Table 4 shows a contingency table for the CAD and group membership.  The hit rate 
for the CAD was found to be 68%.  There were 25% false positives and 7% false negatives.   
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Table 3 
Total Sample Classification Table between RADSa Cutoff and CADb Diagnosis of Depression  
 
        CAD Classification 
             __________________________________ 
 
 RADS Classification Non-depressed Depressed Total 
      Non-depressed 63% 
(n=77) 
16% 
(n=19) 
79% 
(n=96) 
      Depressed 1% 
(n=1) 
20% 
(n=25) 
21% 
(n=26) 
      Total 64% 
(n=78) 
36% 
(n=44) 
100% 
(n=122) 
 
χ2 = 51.74 
aReynolds Adolescent Depression Scale; depression classification based on raw score    
 > 77.   
bClinical Assessment of Depression; depression classification based on T-score > 60.  
  
 21
Table 4 
Classification Table between CADa Diagnosis of Depression and Group Membershipb 
 
        CAD Classification 
            __________________________________ 
 
 Group Membership Non-Significant Depressed Total 
      Non-Referred 57% 
(n=69) 
25% 
(n=30) 
81% 
(n=99) 
      Clinical 7.4% 
(n=9) 
11.5% 
(n=14) 
19% 
(n=23) 
      Total 64% 
(n=78) 
36% 
(n=44) 
100% 
(n=122) 
 
χ2 = 7.56 
aClinical Assessment of Depression; depression classification based on T-score > 60.  
bNon-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23 
individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder, 
Dysthymia, or Depressive Disorder, NOS. 
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The χ2 statistic was significant, χ2 = 7.56, (p < .006) indicating the cell proportions are not a 
chance occurrence.  Table 5 shows a contingency table for the RADS and group membership.  
The hit rate for the RADS was found to be 73%, with 15% false positives and 12% false 
negatives identified.  The χ2 statistic was significant, χ2 = 3.07, (p < .08) indicating the cell 
proportions are not a chance occurrence.       
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Table 5 
Classification Table between RADSa Diagnosis of Depression and Group Membershipb 
 
           RADS Classification 
                    __________________________________ 
 
 Group Membership Non-Significant Depressed Total 
      Non-Referred 66% 
(n=81) 
15% 
(n=18) 
81% 
(n=99) 
      Clinical 12.3% 
(n=15) 
6.6% 
(n=8) 
19% 
(n=23) 
      Total 79% 
(n=96) 
21% 
(n=26) 
100% 
(n=122) 
 
χ2 = 3.07 
aReynolds Adolescent Depression Scale; depression classification based on T-score > 77.  
bNon-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23 
individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder, 
Dysthymia, or Depressive Disorder, NOS. 
  
  
Discussion 
The current study expected to find that there is a significant positive correlation 
between the CAD and the RADS for the clinical and non-referred group participants.  Total 
scores were expected to yield moderate to high correlations between the two scales.  In addition, 
the CAD was expected to discriminate between clinical and normal groups of adolescents.  On 
the CAD and the RADS, total scores were to yield significantly higher scores in the clinical 
population than in the normal population.  In addition, classification efficacy was to be 
examined. 
 The first objective of this study was to determine how concurrently the CAD and the 
RADS could identify depressive symptoms in both the clinical and non-referred sample.   
Pearson product moment correlations computed for the RADS total score, CAD total scale score, 
CAD Depressed Mood scale, CAD Anxiety/Worry scale, CAD Diminished Interest scale, and 
CAD Cognitive and Physical Fatigue scale were significant and positive ranging from .70 to .97.  
Using Cohen’s (1988) effect sizes to determine the strength of the correlation, all correlations are 
considered to be strong, accounting for 49% to 94% of the variance between the two measures.  
The weakest correlation (.70) was between the RADS total score and the CAD Cognitive and 
Physical Fatigue scale score; the strongest correlation (.97) was between the CAD total score and 
the CAD Depressed Mood scale score.  The findings support the hypothesis that the CAD will 
evidence strong concurrent validity with the RADS. 
 The next objective of this study was to determine if the CAD could discriminate between 
the clinical and non-referred population.  The RADS was used as the criterion measure due to its 
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empirically validated ability to detect depressive symptoms.  Independent samples t tests were 
computed to examine mean group differences (clinical versus non-referred) of the two scales 
(RADS and CAD).  The t test for each measure was significant.  The t test for the RADS scores 
indicated that the samples can be discriminated on the basis of mean scores.  The t test for the 
CAD indicates that the clinical group had higher mean scores than the non-referred group.  The 
findings support the hypothesis that the clinical group will evidence higher mean scores on the 
two scales than the non-referred group. 
 The final objective of this study was to examine the classification efficacy of the CAD 
using the RADS as the criterion.  Using a 2 x 2 contingency table, the hit rate for the total sample 
was found to be high at 84%.  However, 16% were identified as false positive and one percent as 
false negative.  A false negative occurred when the RADS identified a person as depressed and 
the CAD identified that person as not depressed; this is considered a more liberal classification.  
A false positive occurred when the RADS identified an individual as not depressed and the CAD 
identified that same person as depressed; this can be considered a conservative classification.  A 
false positive, while it is an error, is more conservative in diagnosing depression.  When using 
group membership as a criterion, the CAD produced a hit rate of 68%, with 25% false positives 
and 7% false negatives.  The RADS produced a hit rate of 73%, with 15% false positives and 
12% false negatives.  There are a few explanations that may account for these discrepancies.  
First, there was a small number of clinical participants (n=23) in comparison to the non-referred 
participants (n=99).  A higher hit rate was found in the non-referred population, and this is likely 
due to the larger sample size.  Secondly, major depression is not a stable symptomology.  When 
the clinical participants were diagnosed with depression, the symptoms may have been much 
more severe than they were at the time of participation in this study.  The researcher was not  
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aware of the length of time the clinical participants had been in treatment, and some participants 
were currently on medication at the time of participation.  Depression exists on a continuum, and 
this helps to explain why there would be an expected amount of variation in the severity of the 
ratings made by the clinical participants.    
Limitations 
 While valuable information can be obtained from this study, there are limitations that 
could affect the interpretation of the results.  Low sample size, particularly in the clinical 
population, may have limited the amount of information that was gathered.  Also, clinical 
participants were recruited through both inpatient and outpatient facilities, which may explain 
some of the discrepancy in classification within that sample.      
 A threat to the internal validity of the study was the differential selection of the 
participants.  The clinical participants were all receiving services; it is possible that there was 
something unique about the clinical sample (being in treatment) that affected the results.  There 
were threats to the external validity of the study as well.  The clinical sample was not completely 
homogenous in that it was comprised of three types of diagnoses and had other diagnoses 
secondary to depression and one participant had depression as a secondary diagnosis.  A more 
homogeneous sample would increase confidence in findings.  Another external threat is that the 
study relied on participants in treatment to represent the clinical population; depressed 
individuals who did not seek treatment were not represented in this study.  Therefore, it is 
difficult to say how generalizable the findings of this study are.  A final external threat affects 
data collection.  Data were collected in one geographic region (south-central Kentucky), and 
while the study sample’s ethnicity was representative of the region (7% minority), it is not 
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typical of the United States as a whole.  Therefore, generalizability to other geographic regions 
may not be as valid.                   
Implications 
 Practical implications.  Findings of the current study have strong implications for the 
field of psychology.  As depression measures are limited for child and adolescent populations, it 
is important that additional measures be established. The current study has provided evidence for 
the validity of a newly developed depression scale, the CAD, with adolescents and expanded the 
knowledge base of adolescent depression measures.  With prevalence rates of childhood 
depression on the rise and the high need for identification of depression in adolescents, it is 
imperative that valid, reliable, and standardized measures be established and made accessible.  
Measures that can adequately identify and diagnose depressive symptoms will increase the 
likelihood of accurate treatment. 
  Recommendations for future research.  The present study focused on convergent validity 
with the CAD and RADS, which are two instruments designed specifically for depressive 
symptom identification.  Further investigation with the CAD should explore it’s use with 
inpatient and outpatient settings, individuals over the course of treatment and more 
homogeneously defined clincal groups.  In addition, further investigations might explore  
divergent validity of the CAD with measures that assess a wider range of clinical symptoms, 
including internalizing behaviors such as depression, but also focus on a wider assessment of 
overall symptoms.  Further evidence of validity should be explored through factor analysis.  This 
would help to substantiate the subscale structure of the CAD.  
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Dear Parent/Guardian, 
 
Your child is invited to participate in a study looking at the usefulness of 3 measures of social and 
emotional well-being.  This study is being conducted by Shanna Bowers, Brooke Wootton and Dr. 
Elizabeth Jones of Western Kentucky University in cooperation with your child’s clinician.  The 
results of the study will be used to determine how well these 3 instruments measure social and 
emotional well-being in adolescents.   
 
In addition, the data from this study will be used to evaluate a new instrument that measures  social 
and emotional well-being.  Such data can provide information about the new instruments’ usefulness 
and ability to measure what it sets out to measure.  If you agree to allow your child’s responses to be 
used in this evaluation process, there is a separate consent form included in this packet that requires 
your signature.  This form will be returned to the test publisher.   
 
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires 
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning.  It 
will take approximately 25 minutes to complete and this may be done before or after your child’s 
therapy sessions. You will also be asked to complete a release of information form to allow your 
child’s therapist to release diagnosis, medication, and family history information. This information 
will only be used by the researchers to insure that research requirements are met. Your child’s name 
will not appear on this form.  For your child’s participation in this study he or she will receive a local 
fast food restaurant coupon that will not exceed a $2.00 value. 
  
Your consent and your child’s participation are completely voluntary.  At any time withdrawal from 
the study is possible.  If you do not consent for your child to participate, it will have no negative 
outcomes for you or your child and will not affect the relationship with the clinician.  There are no 
physical risks involved in filling out the questionnaires.  However, answering the items on the 
questionnaires may cause your child to feel some emotional discomfort, due to the nature of the 
questions asked about your child’s behavior. All information collected in this study will be kept 
strictly confidential and will be accessible only to project staff.  However, all packets will be coded 
to allow for identification only if an individual's responses indicate a threat to self or others on the 
questionnaires.  Researchers must by law report this information to your child’s clinician and you 
will be immediately informed.  
 
The procedures in this study have been reviewed and approved by the Western Kentucky University 
Human Subjects Review Board.  If you have questions about the study you may contact Dr. Elizabeth 
Jones by phone at (270) 745-4414.  We hope that both you and your child agree to take part in our study.  
To indicate your consent for participation please complete and sign the attached form, have your child 
complete the questionnaires, and return the packet to your child’s clinician. 
  
Sincerely, 
 
 
Elizabeth L. Jones   Shanna Bowers Brooke Wootton 
Associate Professor of Psychology   School Psychology Graduate Students 
 
 34
 
Participation Consent Form 
 
Child’s Age ____ Child’s Gender  __ M   __F    Child’s Race/Ethnicity________ 
 
 
I have read the information provided concerning this study.  I give consent for my child to 
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones 
of Western Kentucky University.  I understand that I may withdraw from the study at any time 
without penalty. 
 
 
_____ I DO give consent for my child to participate in this study. 
 
 
_____ I DO NOT give consent for my child to participate in this study. 
 
 
Parent/Guardian Signature ______________________________ Date __________ 
 
 35
 
PARENT/GUARDIAN CONSENT FORM 
Research Participation in a Behavioral Study 
 
General Information and Purpose 
My child:____________________ has been asked to participate in a research study being conducted by 
PAR, Inc., a developer and publisher of educational and behavioral assessment tools.  The purpose of 
the study is to evaluate a new test designed to identify behavioral problems in adolescents.  I have been 
asked to participate in this study because I am the parent of a child (ages 2 to 18 years); if my child is 
between 8 and 18-years-old, he or she has also been asked to participate. 
 
What is involved in my child’s participation? 
If I agree (and give consent for my child) to participate in this study, my child will complete one or more 
questionnaires that ask about my child’s academic, social, and personal behaviors.  Children 
questionnaires take from 15 to 30 minutes to complete. 
 
Risks 
There is no physical risk involved in filling out the questionnaires.  Answering the questions on the 
questionnaires may cause my child to feel some emotional discomfort, due to the nature of the questions 
asked about my child’s behavior. 
 
Benefits 
The results of this study may be of benefit in the future to children with behavioral problems and the 
professionals who evaluate and treat them. There is no immediate benefit to my child for their 
participation, however they may benefit in the event that they indicate suicide or harm to others. If 
such indicators are present, they will be identified and I will be identified immediately.  
 
Confidentiality 
My child’s answers on the questionnaires are strictly confidential and anonymous.  I will not be 
asked to put my child’s name on the questionnaires.  Only the primary researchers or their 
designees will have access to my child’s confidential survey responses.  However, the packets 
will be coded to allow for identification only if my child’s responses indicate suicide or harm to 
others.  By law researchers must report this information to you immediately.  
 
Right to Withdraw or Decline to Participate 
My child’s participation in this study is completely voluntary.  He/she may choose not to participate, or to 
withdraw from participation at any time without penalty. 
 
I attest that I have read and understand all of the above pertaining to my child’s participation in this study, 
and that all of my questions about the study have been answered to my satisfaction.  I hereby give my 
informed consent for my child to participate in this research study. 
 
____________________________  ____________________________    _________ 
Parent’s Name (please print)             Parent’s Signature                                         Date 
If you have any questions regarding this research study or participation in it, please call Michelle Owens or Dr. Mario Rodriguez (Project Director) at 1-866-PAR-
DATA or 1-800-331-TEST.  PAR, Inc./16204 N. Florida Avenue, Lutz FL 33549/Tel (813)968-3003/Fax (813)968-4684 
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Release of Information 
CONCURRENT VALIDITY STUDY OF ADOLESCENT DEPRESSION MEASURES 
 
 
 
(1) TO:_______________________________  (2) DATE:__________________ 
 
       _______________________________ 
 
       _______________________________ 
 
  
(3) RE:___________________________ 
        Name 
             ___________________________ 
        Address 
 
Authorization is hereby granted to release to Western Kentucky University (WKU) researchers: Dr. Elizabeth Jones, 
Shanna Bowers, and Brooke Wootton, and Psychological Assessment Resources (PAR) researchers such 
information relative to service rendered.   
 
              
             (4) ___________________________ 
        Signature of Parent 
 
              ___________________________ 
        Address 
 
              ___________________________ 
       
 
 
 
(5) ____________________________         ___________________________ 
      Witness          Date 
 
 
Information particularly requested is listed below: 
Your Childs: Age   
Gender 
  Race  
  Primary DSM-IV Diagnosis 
  List of Current Medications 
  Family History of DSM-IV Diagnosis  
 
 37
 
As mentioned before, the purpose of this study is to use self-report measures to identify social 
and emotional well-being in adolescents.  To ensure that the participants of this study meet 
diagnosis criteria, it is necessary to obtain diagnosis information from a clinician.   
 
Attached is a release form that must be completed so that your child’s therapist can release 
diagnosis and medication information to the researchers. 
 
• Fill in the name of your child’s therapist at #1 
 
• Put today’s date at #2 
 
• Put your child’s name at #3 
 
• Sign your name, provide address and date at #4 
 
• Have a witness (someone over 18 years of age) sign at #5 
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Participation Assent Form 
 
I have read and understand the information provided about this study.  I give assent to participate 
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western 
Kentucky University.  I understand that I may withdraw from this study at any time without 
penalty. 
 
I, ________________________, understand that my parent/guardian has given permission for 
me to participate in a study concerning social and emotional well-being, under the direction of 
Western Kentucky University. 
 
My participation in this project is completely voluntary, and I understand that I may stop my 
participation in this study at any time.  I am aware that I am encouraged to answer all of the 
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items.   If 
I choose not to participate, it will not affect my treatment in any way. 
 
Signature _________________________  Date____________ 
 
  
 
Clinician Record Form
Date: ________________Clinician Name:_____________________________________
Please provide the following information for the individual participant being rated/tested. 
Age: _____
ID No.: _____________________ Gender: ______ Race/Ethnicity: ____________
Primary DSM-IV Diagnosis(es): _____________________________________________________
Estimated Date of Dx: ______________ 
        Psychiatrist 
        Primary care physician 
        Other: _______________ 
Diagnosis made by:         Psychologist 
       Pediatrician 
      School Personnel1) ________________ 
Current?
Yes No 
Yes No 
Yes No 
Estimated Date of Dx: ______ Secondary 
DSM-IV 
Diagnoses: Estimated Date of Dx:_______ 2) ________________
Estimated Date of Dx: _______ 3) ________________
Current Psychotropic Medications: 1) ___________________________________________
2) ___________________________________________
3) ___________________________________________
Does either parent or any sibling carry a DSM-IV diagnosis(es)? 
If yes, indicate biological relative(s) and respective diagnosis(es):
  Mother Diagnosis( es): ____________________________________________________ 
  Father Diagnosis( es):_____________________________________________________
  Sibling 1 Diagnosis( es):_____________________________________________________
  Sibling 2 Diagnosis( es):_____________________________________________________
  Sibling 3 Diagnosis( es):_____________________________________________________
  Sibling 4 Diagnosis( es):_____________________________________________________
  Sibling 5 Diagnosis( es):_____________________________________________________
   Yes  No 
 
09/11/01
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Dear Parent/Guardian, 
 
Your child is invited to participate in a study looking at the usefulness of 3 measures of social 
and emotional well-being used with adolescents.  This study is being conducted by Shanna 
Bowers, Brooke Wootton and Dr. Elizabeth Jones of Western Kentucky University.  The results 
of the study will be used to determine how well these 3 instruments measure social and 
emotional well-being in adolescents.   
 
In addition, the results of this study will be used to evaluate a new instrument that measures 
social and emotional well-being. Such data can provide information about the new instrument’s 
usefulness and ability to measure what it sets out to measure.  If you agree to allow your child’s 
responses to be used in this evaluation process, there is a separate consent form included in this 
packet that requires your signature.  This form will be returned to the test publisher. 
 
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires 
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning.  
It will take approximately 25 minutes to complete the three questionnaires.  
For your child’s participation in this study he or she will receive a local fast food restaurant 
coupon that will not exceed a $2.00 value.  
 
Your consent and your child’s participation are completely voluntary.  At any time withdrawal 
from the study is possible.  If you do not consent for your child to participate, it will have no 
negative outcomes for you or your child.  There are no physical risks involved in filling out the 
questionnaires.  However, answering the items on the questionnaires may cause your child to feel 
some emotional discomfort, due to the nature of the questions asked about your child’s behavior.  
All information collected in this study will be kept strictly confidential and will be accessible 
only to the project staff. However, all packets will be coded to allow for identification only if an 
individual's responses indicate a threat to self or others on the questionnaires.  Researchers must 
by law report this information to you immediately.  
 
The procedures in this study have been reviewed and approved by the Western Kentucky 
University Human Subjects Review Board.  If you have questions about the study you may 
contact Dr. Elizabeth Jones by phone at (270) 745-4414.  We hope that both you and your child 
agree to take part in our study.  To indicate your consent for participation please complete and 
sign the attached form. 
 
Sincerely, 
 
 
Elizabeth L. Jones   Shanna Bowers Brooke Wootton 
Associate Professor of Psychology   School Psychology Graduate Students 
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Participation Consent Form 
 
Child’s Age ____ Child’s Gender  __ M   __F     Child’s Race/Ethnicity________  
 
I have read the information provided concerning this study.  I give consent for my child to 
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones 
of Western Kentucky University.  I understand that I may withdraw from the study at any time 
without penalty. 
 
 
_____ I DO give consent for my child to participate in this study. 
 
 
_____ I DO NOT give consent for my child to participate in this study. 
 
 
Parent/Guardian Signature_______________________________ Date __________ 
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Participation Assent Form 
 
I have read and understand the information provided about this study.  I give assent to participate 
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western 
Kentucky University.  I understand that I may withdraw from this study at any time without 
penalty. 
 
I, ________________________, understand that my parent/guardian has given permission for 
me to participate in a study concerning social and emotional well-being, under the direction of 
Western Kentucky University. 
 
My participation in this project is completely voluntary, and I understand that I may stop my 
participation in this study at any time.  I am aware that I am encouraged to answer all of the 
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items. 
Whether or not I choose to participate, I will not be affected in any way. 
 
Signature _________________________  Date____________ 
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WESTERN KENTUCKY UNIVERSITY  
Human Subjects Review Board  
Office of Sponsored Programs  
104 Foundation Building  
270-745-4652; Fax 270-745-4211  
E-mail: Phillip.Myers@Wku.Edu  
In future correspondence please refer to HS03-077, April 3, 2003 
Shanna Bowers  
1500 Crossbreeze Ct.  
Bowling Green, KY 42104  
 
Dear Shanna: 
  
Your research project, "Concurrent Validity of Adolescent Depression Measures," was reviewed by the 
HSRB and it has been determined that risks to subjects are: (1) minimized and reasonable; and that (2) 
research procedures are consistent with a sound research design and do not expose the subjects to 
unnecessary risk. Reviewers determined that: (1) benefits to subjects are considered along with the 
importance of the topic and that outcomes are reasonable; (2) selection of subjects is equitable; and (3) 
the purposes of the research and the research setting is amenable to subjects' welfare and producing 
desired outcomes; that indications of coercion or prejudice are absent, and that participation is clearly 
voluntary.  
1. In addition, the IRB found that: (1) signed informed consent will be obtained from all subjects. (2) 
Provision is made for collecting, using and storing data in a manner that protects the safety and privacy of 
the subjects and the confidentiality of the data. (3) Appropriate safeguards are included to protect the 
rights and welfare of the subjects. (4) Any ad or flyer used to recruit participants must be reviewed 
by the HSRB before used.  
a. Your research therefore meets the criteria of Full Board Review and is Approved.  
2. Please note that the institution is not responsible for any actions regarding this protocol before 
approval. If you expand the project at a later date to use other instruments please re-apply. Copies of your 
request for human subjects review, your application, and this approval, are maintained in the Office of 
Sponsored Programs at the above address. Please report any changes to this approved protocol to this 
office. A Continuing Review protocol will be sent to you in the future to determine the status of the 
project.  
Sincerely,  
Phillip E. Myers, Ph.D.  
Director, OSP and  
Human Protections Administrator  
 
cc: Human Subjects File HS03-077  
cc: Brooke Wootton  
cc: Dr. Elizabeth Jones  
 
